ImmunityBio

ImmunityBio

Verified
ImmunityBio pioneers innovative therapies to conquer disease through immune system reprogramming.

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
USD2020202120222023202420252026
Revenues0000000000000000000000000000
% growth(73 %)54 %(74 %)159 %1456 %775 %133 %
EBITDA0000000000000000000000000000
% EBITDA margin(32253 %)(33866 %)(143324 %)(62077 %)---
Profit0000000000000000000000000000
% profit margin(36670 %)(37130 %)(173570 %)(93761 %)(4513 %)(362 %)(93 %)
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000
R&D % of revenue23059 %20981 %103395 %37358 %---
  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor

$0.0

round
N/A

$0.0

round
investor

$0.0

round
N/A

$0.0

round
investor

$0.0

round
investor

$0.0

round
*

$300m

Post IPO Debt
Total Funding000k

Recent News about ImmunityBio

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.